Clinical efficacy and safety of etoricoxib and meloxicam in treating acute gout

Objective To analyze the clinical effect and safety of etoricoxib and meloxicam in treating acute gout.Methods 120 cases of patients with acute gout treated in our hospital from January 2010 to January 2013 were selected as research objects and were divided into etoricoxib group and meloxicam group randomly,each group for 60 cases.Etoricoxib group were treated with etoricoxib,120 mg/d.Meloxicam group were treated with meloxicam,15 mg/d.The self score of pain of patients was measured,and the adverse reactions were recorded.Results After treatment,the joint pain scores of two groups were down,and etoricoxib group improved more better than that of meloxicam group,the differences were sinificant(P0.05).The incidence of etoricoxib group was 30.0%,and the meloxicam group was 33.3%,there was no significant difference between the two groups(P0.05).Conclusion The clinical efficacy of etoricoxib is better than that of meloxicam.